|
|
Doximity Inc (NYSE: DOCS) |
|
Price: $53.7200
$0.51 
0.958%
|
| Day's High:
| $54.43
| Week Perf:
| 8.07 %
|
| Day's Low: |
$ 52.95 |
30 Day Perf: |
0.83 % |
| Volume (M): |
789 |
52 Wk High: |
$ 61.75 |
| Volume (M$): |
$ 42,396 |
52 Wk Avg: |
$35.59 |
| Open: |
$53.22 |
52 Wk Low: |
$22.96 |
|
|
| Market Capitalization (Millions $) |
10,766 |
| Shares
Outstanding (Millions) |
200 |
| Employees |
1,000 |
| Revenues (TTM) (Millions $) |
516 |
| Net Income (TTM) (Millions $) |
174 |
| Cash Flow (TTM) (Millions $) |
76 |
| Capital Exp. (TTM) (Millions $) |
6 |
Doximity Inc
Doximity Inc is an intermediary mobile communication platform for medical professionals, providing them with a secure and private network where they can collaborate, communicate, and stay up-to-date with the latest trends in the medical industry. The company was started in 2011 by Dr. Jeff Tangney and Shari Buck, with a mission to connect medical professionals in a way that makes their jobs easier, drives patient care improvement, and promotes lifelong learning.
The Doximity network is built on a platform that offers advanced encryption and security protocols to ensure sensitive medical information remains private and secure. Medical professionals can use the service to share patient information, communicate with other providers, and access medical research and best practices. The network enables physicians to collaborate across specialties and locations and be more productive on the go. Doximity also offers a job board, where medical professionals can find job opportunities and connect with potential employers.
Doximity has over5 million verified medical professionals registered on its platform, which represents over 80% of all U.S. physicians. It is the largest professional medical network in the United States, and it includes healthcare professionals from over 70 specialties. The company is headquartered in San Francisco, California, with offices in Durham, North Carolina, and Toronto, Canada.
Doximity Inc has received several awards and recognition for its innovative work, including being named to the Forbes Cloud 100 list and recognized as one of Fast Company's Most Innovative Companies in Healthcare. The company has also received significant financial investment from top venture capital firms, including Morgenthaler Ventures, Emergence Capital, and InterWest Partners.
Overall, Doximity Inc is a cutting-edge and innovative medical platform that provides a vital service for medical professionals in the United States. By fostering communication and collaboration between physicians, the company is driving meaningful improvements in patient outcomes and promoting lifelong learning for medical professionals.
Company Address: 500 3rd St. San Francisco 94107 CA
Company Phone Number: 549-4330 Stock Exchange / Ticker: NYSE DOCS
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Announcement
Published Tue, Jun 4 2024 4:39 PM UTC
Rosen Law Firm, a reputable global investor rights law firm, is urging investors who purchased common stock of Doximity, Inc. (NYSE: DOCS) between February 9, 2022, and April 1, 2024 (the Class Period), to secure legal representation before the crucial June 17, 2024 lead plaintiff deadline. The company previously issued a reminder regarding this deadline on May 23, 2024, emp...
|
| Announcement
Published Tue, May 28 2024 3:28 PM UTC
The Fall of Doximity: A Class Action Lawsuit and Its Consequences In the corporate world, nothing strikes terror quite like the words class action lawsuit. For shareholders of Doximity, Inc. (NYSE: DOCS), the recent announcement from Pomerantz LLP rings alarm bells loud and clear. The acclaimed law firm, known for representing shareholder interests, filed a class action la...
|
| Doximity Inc
Doximity Inc, a leading digital platform for U.S. medical professionals, recently released its financial results for the fiscal year ending March 31, 2024. The company reported significant growth in revenue, profit per share, and net earnings. However, amidst these positive developments, Doximity Inc faces a securities class action lawsuit that could potentially impact its stock and investors.
Financial Results Overview:
Doximity Inc reported a 45.65% increase in profit per share for the financial year ending March 31, 2024. The figure rose from $0.15 per share to $0.21 per share, indicating strong profitability. In comparison to the prior reporting season, profits fell by -10.69% from $0.24 per share.
|
| Announcement
Published Thu, May 23 2024 9:23 PM UTC
In recent news, Rosen Law Firm, a renowned global investor rights law firm, has issued a reminder to individuals who purchased common stock of Doximity, Inc. (NYSE: DOCS) between February 9, 2022, and April 1, 2024. The law firm has advised investors to secure legal counsel ahead of the June 17, 2024 deadline for the selection of a lead plaintiff in an ongoing securities cla...
|
| Doximity Inc
Doximity Inc. (NYSE: DOCS) has certainly had an impressive financial interval closing December 31, 2023, with significant increases in profit per share, revenue, EPS, and net profits. The company's profit margins have also improved, with both net margin and operating margin showing positive growth. Additionally, the build-up in accounts receivable is a strong indicator of rising demand for Doximity's services.
However, despite these positive financial results, there are several reasons to be cautious about the future prospects of Doximity Inc. One major concern is the slowing growth in the company's share price. In the month of February alone, Doximity Inc. shares went down by -0.36%, bringing the share price to -4.06% during the first quarter of 2024. This indicates that investors may be losing confidence in the company's ability to sustain its growth trajectory.
|
| Per Share |
Current |
| Earnings (TTM) |
0.88 $ |
| Revenues (TTM) |
2.57 $
|
| Cash Flow (TTM) |
0.38 $ |
| Cash |
0.92 $
|
| Book Value |
4.8 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
0.88 $
|
| Revenues (TTM) |
2.57 $ |
| Cash Flow (TTM) |
0.38 $ |
| Cash |
0.92 $
|
| Book Value |
4.8 $ |
| Dividend (TTM) |
0 $ |
|
|
| |
| Subscription |
|
 95.21 % |
of total Revenue |
| Other |
|
5.28 % |
of total Revenue |
|
|
11.31% 